Structural Biology and Bioinformatics, Department of Biochemistry, University of Melbourne, Parkville, VIC 3052, Australia.
Systems and Computational Biology, Bio21 Institute, University of Melbourne, Parkville, VIC 3052, Australia.
Genes (Basel). 2023 Sep 29;14(10):1890. doi: 10.3390/genes14101890.
Variants in non-homologous end joining (NHEJ) DNA repair genes are associated with various human syndromes, including microcephaly, growth delay, Fanconi anemia, and different hereditary cancers. However, very little has been done previously to systematically record the underlying molecular consequences of NHEJ variants and their link to phenotypic outcomes. In this study, a list of over 2983 missense variants of the principal components of the NHEJ system, including DNA Ligase IV, DNA-PKcs, Ku70/80 and XRCC4, reported in the clinical literature, was initially collected. The molecular consequences of variants were evaluated using in silico biophysical tools to quantitatively assess their impact on protein folding, dynamics, stability, and interactions. Cancer-causing and population variants within these NHEJ factors were statistically analyzed to identify molecular drivers. A comprehensive catalog of NHEJ variants from genes known to be mutated in cancer was curated, providing a resource for better understanding their role and molecular mechanisms in diseases. The variant analysis highlighted different molecular drivers among the distinct proteins, where cancer-driving variants in anchor proteins, such as Ku70/80, were more likely to affect key protein-protein interactions, whilst those in the enzymatic components, such as DNA-PKcs, were likely to be found in intolerant regions undergoing purifying selection. We believe that the information acquired in our database will be a powerful resource to better understand the role of non-homologous end-joining DNA repair in genetic disorders, and will serve as a source to inspire other investigations to understand the disease further, vital for the development of improved therapeutic strategies.
非同源末端连接 (NHEJ) DNA 修复基因中的变异与各种人类综合征有关,包括小头畸形、生长迟缓、范可尼贫血症和不同的遗传性癌症。然而,以前很少有系统地记录 NHEJ 变体的潜在分子后果及其与表型结果的联系。在这项研究中,最初收集了一份主要 NHEJ 系统组成部分(包括 DNA 连接酶 IV、DNA-PKcs、Ku70/80 和 XRCC4)的超过 2983 个错义变体的列表,这些变体是在临床文献中报道的。使用计算生物物理工具评估变体的分子后果,以定量评估它们对蛋白质折叠、动力学、稳定性和相互作用的影响。对这些 NHEJ 因子中的致癌和人群变体进行了统计分析,以确定分子驱动因素。从已知在癌症中发生突变的基因中精心整理了一份全面的 NHEJ 变体目录,为更好地了解它们在疾病中的作用和分子机制提供了资源。变体分析突出了不同蛋白质之间的不同分子驱动因素,锚定蛋白(如 Ku70/80)中的致癌变体更有可能影响关键的蛋白质-蛋白质相互作用,而酶成分(如 DNA-PKcs)中的变体更有可能存在于经历纯化选择的不耐受区域。我们相信,我们数据库中获得的信息将成为更好地理解非同源末端连接 DNA 修复在遗传疾病中的作用的有力资源,并将作为激发其他研究以进一步了解疾病的来源,这对于开发改进的治疗策略至关重要。